Wanbury Limited (NSE:WANBURY)
India flag India · Delayed Price · Currency is INR
268.45
-0.45 (-0.17%)
Aug 1, 2025, 3:29 PM IST

Wanbury Company Description

Wanbury Limited manufactures and sells formulations and active pharmaceutical ingredients (API) in India and internationally.

The company offers formulations for gynecology, orthopedics, hematinic, anti-diabetic, nutraceuticals, gastro intestinal, stroke surgery, antibiotics, cough and cold solutions, anti-inflammatory, analgesics, and general practitioner.

It also provides API products for anti-diabetic, anti-analgesic, anti-depressant, anti-histaminic, anti-inflammatory, anti-arthritis, anti-thrombotic, anti-epileptic, and anti-hypertensive therapeutic areas.

The company was formerly known as Pearl Organics Limited and changed its name to Wanbury Limited in 2004.

Wanbury Limited was incorporated in 1988 and is headquartered in Navi Mumbai, India.

Wanbury Limited
Wanbury logo
CountryIndia
Founded1988
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
Employees1,491
CEOMohan Rayana

Contact Details

Address:
BSEL Tech Park, B-Wing
Navi Mumbai, Maharashtra 400703
India
Phone91 22 6794 2222
Websitewanbury.com

Stock Details

Ticker SymbolWANBURY
ExchangeNational Stock Exchange of India
Fiscal YearApril - March
Reporting CurrencyINR
ISIN NumberINE107F01022
SIC Code2834

Key Executives

NamePosition
Pradeep PatniChief Executive Officer of India Formulation Business
Mohan Kumar RayanaWhole Time Director
Krishnamoorthy ChandranVice Chairman
Vinod R. VermaChief Financial Officer
Jitendra Jayantilal GandhiCompliance Officer and Company Secretary
Dr. Shireesh Bhalchandra AmbhaikarPresident of Operations - API Business
Nanasaheb GunjalSenior Vice President of QA,QC and RA
Prakash Venkataraman B.E., MBAHead of API Business